22438809|t|Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.
22438809|a|Pulmonary Francisella tularensis and Burkholderia pseudomallei infections are highly lethal in untreated patients, and current antibiotic regimens are not always effective. Activating the innate immune system provides an alternative means of treating infection and can also complement antibiotic therapies. Several natural agonists were screened for their ability to enhance host resistance to infection, and polysaccharides derived from the Acai berry (Acai PS) were found to have potent abilities as an immunotherapeutic to treat F. tularensis and B. pseudomallei infections. In vitro, Acai PS impaired replication of Francisella in primary human macrophages co-cultured with autologous NK cells via augmentation of NK cell IFN-gamma. Furthermore, Acai PS administered nasally before or after infection protected mice against type A F. tularensis aerosol challenge with survival rates up to 80%, and protection was still observed, albeit reduced, when mice were treated two days post-infection. Nasal Acai PS administration augmented intracellular expression of IFN-gamma by NK cells in the lungs of F. tularensis-infected mice, and neutralization of IFN-gamma ablated the protective effect of Acai PS. Likewise, nasal Acai PS treatment conferred protection against pulmonary infection with B. pseudomallei strain 1026b. Acai PS dramatically reduced the replication of B. pseudomallei in the lung and blocked bacterial dissemination to the spleen and liver. Nasal administration of Acai PS enhanced IFN-gamma responses by NK and gammadelta T cells in the lungs, while neutralization of IFN-gamma totally abrogated the protective effect of Acai PS against pulmonary B. pseudomallei infection. Collectively, these results demonstrate Acai PS is a potent innate immune agonist that can resolve F. tularensis and B. pseudomallei infections, suggesting this innate immune agonist has broad-spectrum activity against virulent intracellular pathogens.
22438809	6	26	Acai polysaccharides	Chemical	-
22438809	83	105	Francisella tularensis	Species	263
22438809	110	146	Burkholderia pseudomallei Infections	Species	
22438809	158	180	Francisella tularensis	Species	263
22438809	185	221	Burkholderia pseudomallei infections	Species	
22438809	253	261	patients	Species	9606
22438809	399	408	infection	Disease	MESH:D007239
22438809	542	551	infection	Disease	MESH:D007239
22438809	557	572	polysaccharides	Chemical	MESH:D011134
22438809	602	609	Acai PS	Chemical	-
22438809	680	693	F. tularensis	Species	263
22438809	698	724	B. pseudomallei infections	Species	
22438809	768	779	Francisella	Species	263
22438809	791	796	human	Species	9606
22438809	874	883	IFN-gamma	Gene	3458
22438809	898	905	Acai PS	Chemical	-
22438809	943	952	infection	Disease	MESH:D007239
22438809	963	967	mice	Species	10090
22438809	983	996	F. tularensis	Species	263
22438809	1102	1106	mice	Species	10090
22438809	1134	1143	infection	Disease	MESH:D007239
22438809	1151	1158	Acai PS	Chemical	-
22438809	1212	1221	IFN-gamma	Gene	15978
22438809	1250	1263	F. tularensis	Species	263
22438809	1273	1277	mice	Species	10090
22438809	1301	1310	IFN-gamma	Gene	15978
22438809	1344	1351	Acai PS	Chemical	-
22438809	1369	1376	Acai PS	Chemical	-
22438809	1416	1435	pulmonary infection	Disease	MESH:D012141
22438809	1441	1469	B. pseudomallei strain 1026b	Species	
22438809	1471	1478	Acai PS	Chemical	-
22438809	1519	1534	B. pseudomallei	Species	28450
22438809	1632	1639	Acai PS	Chemical	-
22438809	1649	1658	IFN-gamma	Gene	15978
22438809	1679	1689	gammadelta	Gene	
22438809	1736	1745	IFN-gamma	Gene	15978
22438809	1789	1796	Acai PS	Chemical	-
22438809	1815	1840	B. pseudomallei infection	Species	
22438809	1941	1954	F. tularensis	Species	263
22438809	1959	1985	B. pseudomallei infections	Species	

